U.S. Strategic Roadmap for New Approaches to Evaluate the Safety of Chemicals and Medical Products.
ICCVAM coordinated the development of "A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States." The roadmap was developed with participation from 16 federal agencies and multiple interagency workgroups, as well as input from a broad range of stakeholder groups. It describes a new framework for the development of enabling technologies and promotion of strategies to establish confidence in, and ensure utilization of, new toxicity testing approaches that improve human health relevance and reduce or eliminate the need for testing in animals. The successful development and implementation of these new approaches will require coordinated efforts that address three strategic goals:
--Connecting end-users with developers of new approach methodologies
--Fostering the use of efficient, flexible, and robust practices to establish confidence in new methods
--Encouraging the adoption and use of new methods and approaches by federal agencies and regulated industries
Activities are already underway to address the roadmap goals in the areas of skin sensitization, skin and eye irritation, and acute systemic toxicity testing. Reviews of U.S. agency information requirements for all of these areas are being prepared and are planned for publication in 2018.
The roadmap was published in January 2018; the roadmap document and related information can be found at https://ntp.niehs. nih.gov/go/natl-strategy.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||UNITED STATES ICCVAM: Advancing Alternatives to Animal Testing|
|Publication:||ALTEX: Alternatives to Animal Experimentation|
|Article Type:||Brief article|
|Date:||Jan 1, 2018|
|Next Article:||ICCVAM Sponsors Project on Predictive Models for Acute Oral Toxicity.|